Last updated on April 2019

Clinical Trial of Efficacy and Safety of Tenoten for Children Liquid Dosage Form in the Treatment of Sequelae of Perinatal Injury to Central Nervous System in Children


Brief description of study

Purpose of the study: - To assess clinical efficacy of Tenoten for children liquid dosage form (oral drops at a daily dose of 10 drops, for 12 weeks) in the treatment of sequelae of perinatal injury to central nervous system (CNS) (cerebral hypoxic-ischaemic event and/or grade I or II intracranial haemorrhage). - To assess safety of Tenoten for children liquid dosage form (oral drops at a daily dose of 10 drops, for 12 weeks) in the treatment of sequelae of perinatal injury to CNS (cerebral hypoxic-ischaemic event and/or grade I or II intracranial haemorrhage).

Clinical Study Identifier: NCT03159611

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.